JPMorgan maintained its overweight rating on Hindalco with a target price of Rs 565 which translates into an upside of over 36 per cent from Rs 414 recorded on August 3, 2022.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.